Diamond Ranch Foods (PLPL) 0.2720 $PLPL
Uruguayan Government Grants Plandai Biotechnology Provisional License for the Research & Development of Prescription Cannabinoid Medicines
Marketwired - Thu May 14, 8:02AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, announced today that the Government of Uruguay, through its Institute of Regulation and Control of Cannabis (IRCCA), granted Plandai Biotechnology Uruguay S.A. a provisional license under the Marijuana and Derivates Law 19.172, Decree No.46/2015, Articles 6 and 9, to establish a scientific program for the research, and development of prescription cannabinoid medicines.
Plandai Biotechnology, Inc. Receives First Purchase Order in Exclusive Supplier Agreement With USN
Marketwired - Wed May 13, 8:03AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , producer of the highly bioavailable Phytofare® catechin complex, today announced that it has received the first purchase order from the Company's exclusive 3-year agreement to supply USN Worldwide with commercial amounts of Phytofare® catechin complex. The Company expects to satisfy the purchase order, which was received from one of USN's contract manufacturers in the South African market, this week.
Plandai Biotechnology, Inc. Signs Agreement to Become Exclusive Supplier to USN
Marketwired - Mon May 11, 8:02AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , producer of the highly bioavailable Phytofare® catechin complex, today announced its entry into an exclusive 3 year supply agreement with USN Worldwide. Pursuant to the contract, the Company will initially sell to USN commercial amounts of Phytofare® catechin complex for USN'S South African markets. Ultimately, the parties intend to expand USN's purchases globally into other territories in which USN operates.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VIII
Anthony Cataldo - at Seeking Alpha - Mon Apr 20, 7:25AM CDT
QAI: 30.06 (-0.03)
New Video Documents Plandai Biotechnology's $20 Million Operation at Senteeko Tea Estate
Marketwired - Tue Apr 14, 7:31AM CDT
Plandaà Biotechnology (OTCQB: PLPL) and its operations at the Senteeko tea estate in South Africa are the subject of a newly released video. Stock Market Media Group, a content development investment relations firm, spent a week in South Africa with a camera crew from Bay Colony Media documenting the company's story, and announced today that the documentary is now available.
Plandai Biotechnology's Production Facility Is an Intricate Maze of Proprietary Equipment Producing an Unmistakable Green Tea Extract
Marketwired - Thu Apr 02, 8:01AM CDT
After years of hard work, Plandaà Biotechnology (OTCQB: PLPL) has everything in place to start realizing the long-time dream of the company's CEO Roger Duffield. That dream has been to produce and sell a much higher bioavailable green tea product than the market currently offers. Duffield has always known he could produce a product that is higher in bioavailability than the competition, but now he has the clinical trials to prove his claims.
Plandai Biotechnology Revives Senteeko Tea Estate Into Something to Be Appreciated
Marketwired - Mon Mar 16, 8:02AM CDT
Prior to heading to South Africa in an effort to document Plandaà Biotechnology's (OTCQB: PLPL) operations there, the only images we at Stock Market Media Group had of the Senteeko Tea Estate were those that have been published on the company's website. So, our journey north to the province of Mpumalanga, South Africa, after spending an enlightening day at North West University with Professor Anne Grobler and her team, was filled with anticipation of what exactly Plandaà has built there.
Plandai Biotechnology Producing a More Potent Product Than First Reported
Marketwired - Mon Mar 09, 8:01AM CDT
Plandaà Biotechnology (OTCQB: PLPL) has probably chosen to err on the side of "under promise and over deliver" when it comes to the bioavailability of its green tea extract, Phytofare® Catechin Complex. At least after sitting across the desk from North West University's Professor Anne Grobler, that is the conclusion one could reach regarding what Plandaà has said about its highly bioavailable extract to date.
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 59.68 (+0.68), FULL: 3.52 (unch), CARA: 10.05 (+0.06)
Plandai Biotechnology, Inc. Secures Collaboration Agreement to Further Company's Cannabis Research in Uruguay
Marketwired - Mon Jan 26, 8:03AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that its wholly-owned Uruguay subsidiary has executed a research agreement with the Foundation for the Development of Basic Sciences ("FUNDACIBA" and the Group of Medicinal Chemistry ("GQM" from the School of Science at the University of the Republic in Montevideo, Uruguay.
Plandai Biotechnology to Use "Trojan Horse" to Make Highly Bioavailable Products Even Stronger
Marketwired - Tue Jan 20, 8:05AM CST
Plandaà Biotechnology (OTCQB: PLPL) proved in a bioavailability study performed at North West University in South Africa, that its green tea Phytofare® Catechin Complex demonstrates ten times greater bioavailability over that of a generic catechin extract. Bioavailability is a fancy word for how much of the dosage of a drug or substance like PlandaÃ's extract gets absorbed into our bloodstream so it can actually be effective. The three-part human clinical trial proved in part two of the study that all 8 catechins that make up the green tea plant made it into the bloodstream of the 26 participants, and those catechins stayed in the bloodstream 5 times longer than the generic extract that PlandaÃ's product was compared to in the study.
Plandai Biotechnology, Inc.'s CEO Discusses Company's Plans for 2015
Marketwired - Fri Jan 09, 8:00AM CST
Plandaà Biotechnology (OTCQB: PLPL) recently updated shareholders on a list of accomplishments reached in 2014, so Stock Market Media Group (SMMG), a research and content development investment relations firm, spoke with PlandaÃ's Chief Executive Officer, Roger Duffield, to discuss PlandaÃ's plans for 2015.
Plandai Biotechnology, Inc. Provides Year-End Shareholder Update
Marketwired - Wed Dec 31, 8:00AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today provided an update to shareholders that reviews the company's accomplishments over the preceding twelve months.
Plandai Biotechnology, Inc. Announces Completion of $13 Million Production Facility
Marketwired - Mon Dec 22, 8:01AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , a developer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced completion of the Company's production facility in South Africa. Further, the Company announced that samples from the first batch of Phytofare® Catechin Complex, which is derived from green tea, are being delivered to testing facilities for final profiling which will take place once vendors return from holiday. Additionally, samples are being sent to North West University to complete their clinical trials and to potential customers for evaluation. Over the coming days the factory will increase its manufacturing production with the expectation that the Company will then be ready to accept and fill customer orders.
Plandai Biotechnology wins halaal certification for Senteeko facility in South Africa
M2 - Mon Dec 15, 6:12AM CST
Health plant extracts company Plandai Biotechnology (OtherOTC
LPL) revealed on Friday the receipt of the halaal certification for its Senteeko production facility in South Africa.
Plandai Biotechnology, Inc. Receives Halaal Certification for Senteeko Facility
Marketwired - Fri Dec 12, 8:00AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Green Gold Biotechnologies Inc., a South African subsidiary of Plandaà which runs the Senteeko production facility, has received Halaal Certification in South Africa. Halaal certification is the process that food producers undergo to establish that they are producing products in accordance with Islamic Law and is seen as a necessary step before shipments can commence to various parts of the world.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 112.93 (+0.68), FULL: 3.52 (unch)
Uruguay's Presidential Election Favors Plandai Biotechnology's Future Cannabis Research
Marketwired - Thu Dec 04, 8:06AM CST
Timing is everything and when Plandaà Biotechnology (OTCQB: PLPL) was given the go-ahead to grow cannabis for medical research in Uruguay, little did they know then that a Presidential runoff in that country would be of great interest today. Plandaà got the green light back in September from Uruguay's Minister of Public Health to collaborate with the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo.
Plandai Biotechnology, Inc. Highlighted in Newly Published Article by South Africa's Department of Science & Technology
Marketwired - Mon Dec 01, 8:03AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company" , a developer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that the Company has been highlighted in an article titled "'Secret' Technology Turns Local Farm into Green Tea Extract Factory" in the December edition of the Republic of South Africa's Department of Science & Technology: Public Understanding of Biotechnology Newsletter. The article, which was reviewed by independent experts through the South African Agency for Science and Technology Advancement (SAASTA) Scientific Editorial Process, can be found at: http://www.pub.ac.za/newsletter/02-201412/article-1.html.
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
Marketwired - Tue Nov 18, 11:27PM CST
Plandaà Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the Pheroid® technology to further increase bioavailability in its products. This enhanced bioavailability allows Plandaà to offer a potential solution for many possible viral and infectious diseases.
Uruguayan Government Grants Plandai Biotechnology Provisional License for the Research & Development of Prescription Cannabinoid Medicines
Marketwired - Thu May 14, 8:02AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, announced today that the Government of Uruguay, through its Institute of Regulation and Control of Cannabis (IRCCA), granted Plandai Biotechnology Uruguay S.A. a provisional license under the Marijuana and Derivates Law 19.172, Decree No.46/2015, Articles 6 and 9, to establish a scientific program for the research, and development of prescription cannabinoid medicines. Plandai Biotechnology, Inc. Receives First Purchase Order in Exclusive Supplier Agreement With USN
Marketwired - Wed May 13, 8:03AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, producer of the highly bioavailable Phytofare® catechin complex, today announced that it has received the first purchase order from the Company's exclusive 3-year agreement to supply USN Worldwide with commercial amounts of Phytofare® catechin complex. The Company expects to satisfy the purchase order, which was received from one of USN's contract manufacturers in the South African market, this week. Plandai Biotechnology, Inc. Signs Agreement to Become Exclusive Supplier to USN
Marketwired - Mon May 11, 8:02AM CDT
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, producer of the highly bioavailable Phytofare® catechin complex, today announced its entry into an exclusive 3 year supply agreement with USN Worldwide. Pursuant to the contract, the Company will initially sell to USN commercial amounts of Phytofare® catechin complex for USN'S South African markets. Ultimately, the parties intend to expand USN's purchases globally into other territories in which USN operates. Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VIII
Anthony Cataldo - at Seeking Alpha - Mon Apr 20, 7:25AM CDT
QAI: 30.06 (-0.03)
New Video Documents Plandai Biotechnology's $20 Million Operation at Senteeko Tea Estate
Marketwired - Tue Apr 14, 7:31AM CDT
Plandaà Biotechnology (OTCQB: PLPL) and its operations at the Senteeko tea estate in South Africa are the subject of a newly released video. Stock Market Media Group, a content development investment relations firm, spent a week in South Africa with a camera crew from Bay Colony Media documenting the company's story, and announced today that the documentary is now available.
Plandai Biotechnology's Production Facility Is an Intricate Maze of Proprietary Equipment Producing an Unmistakable Green Tea Extract
Marketwired - Thu Apr 02, 8:01AM CDT
After years of hard work, Plandaà Biotechnology (OTCQB: PLPL) has everything in place to start realizing the long-time dream of the company's CEO Roger Duffield. That dream has been to produce and sell a much higher bioavailable green tea product than the market currently offers. Duffield has always known he could produce a product that is higher in bioavailability than the competition, but now he has the clinical trials to prove his claims.
Plandai Biotechnology Revives Senteeko Tea Estate Into Something to Be Appreciated
Marketwired - Mon Mar 16, 8:02AM CDT
Prior to heading to South Africa in an effort to document Plandaà Biotechnology's (OTCQB: PLPL) operations there, the only images we at Stock Market Media Group had of the Senteeko Tea Estate were those that have been published on the company's website. So, our journey north to the province of Mpumalanga, South Africa, after spending an enlightening day at North West University with Professor Anne Grobler and her team, was filled with anticipation of what exactly Plandaà has built there.
Plandai Biotechnology Producing a More Potent Product Than First Reported
Marketwired - Mon Mar 09, 8:01AM CDT
Plandaà Biotechnology (OTCQB: PLPL) has probably chosen to err on the side of "under promise and over deliver" when it comes to the bioavailability of its green tea extract, Phytofare® Catechin Complex. At least after sitting across the desk from North West University's Professor Anne Grobler, that is the conclusion one could reach regarding what Plandaà has said about its highly bioavailable extract to date.
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 59.68 (+0.68), FULL: 3.52 (unch), CARA: 10.05 (+0.06)
Plandai Biotechnology, Inc. Secures Collaboration Agreement to Further Company's Cannabis Research in Uruguay
Marketwired - Mon Jan 26, 8:03AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that its wholly-owned Uruguay subsidiary has executed a research agreement with the Foundation for the Development of Basic Sciences ("FUNDACIBA" and the Group of Medicinal Chemistry ("GQM" from the School of Science at the University of the Republic in Montevideo, Uruguay. Plandai Biotechnology to Use "Trojan Horse" to Make Highly Bioavailable Products Even Stronger
Marketwired - Tue Jan 20, 8:05AM CST
Plandaà Biotechnology (OTCQB: PLPL) proved in a bioavailability study performed at North West University in South Africa, that its green tea Phytofare® Catechin Complex demonstrates ten times greater bioavailability over that of a generic catechin extract. Bioavailability is a fancy word for how much of the dosage of a drug or substance like PlandaÃ's extract gets absorbed into our bloodstream so it can actually be effective. The three-part human clinical trial proved in part two of the study that all 8 catechins that make up the green tea plant made it into the bloodstream of the 26 participants, and those catechins stayed in the bloodstream 5 times longer than the generic extract that PlandaÃ's product was compared to in the study.
Plandai Biotechnology, Inc.'s CEO Discusses Company's Plans for 2015
Marketwired - Fri Jan 09, 8:00AM CST
Plandaà Biotechnology (OTCQB: PLPL) recently updated shareholders on a list of accomplishments reached in 2014, so Stock Market Media Group (SMMG), a research and content development investment relations firm, spoke with PlandaÃ's Chief Executive Officer, Roger Duffield, to discuss PlandaÃ's plans for 2015.
Plandai Biotechnology, Inc. Provides Year-End Shareholder Update
Marketwired - Wed Dec 31, 8:00AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today provided an update to shareholders that reviews the company's accomplishments over the preceding twelve months.
Plandai Biotechnology, Inc. Announces Completion of $13 Million Production Facility
Marketwired - Mon Dec 22, 8:01AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, a developer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced completion of the Company's production facility in South Africa. Further, the Company announced that samples from the first batch of Phytofare® Catechin Complex, which is derived from green tea, are being delivered to testing facilities for final profiling which will take place once vendors return from holiday. Additionally, samples are being sent to North West University to complete their clinical trials and to potential customers for evaluation. Over the coming days the factory will increase its manufacturing production with the expectation that the Company will then be ready to accept and fill customer orders. Plandai Biotechnology wins halaal certification for Senteeko facility in South Africa
M2 - Mon Dec 15, 6:12AM CST
Health plant extracts company Plandai Biotechnology (OtherOTC
LPL) revealed on Friday the receipt of the halaal certification for its Senteeko production facility in South Africa. Plandai Biotechnology, Inc. Receives Halaal Certification for Senteeko Facility
Marketwired - Fri Dec 12, 8:00AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Green Gold Biotechnologies Inc., a South African subsidiary of Plandaà which runs the Senteeko production facility, has received Halaal Certification in South Africa. Halaal certification is the process that food producers undergo to establish that they are producing products in accordance with Islamic Law and is seen as a necessary step before shipments can commence to various parts of the world. American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 112.93 (+0.68), FULL: 3.52 (unch)
Uruguay's Presidential Election Favors Plandai Biotechnology's Future Cannabis Research
Marketwired - Thu Dec 04, 8:06AM CST
Timing is everything and when Plandaà Biotechnology (OTCQB: PLPL) was given the go-ahead to grow cannabis for medical research in Uruguay, little did they know then that a Presidential runoff in that country would be of great interest today. Plandaà got the green light back in September from Uruguay's Minister of Public Health to collaborate with the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo.
Plandai Biotechnology, Inc. Highlighted in Newly Published Article by South Africa's Department of Science & Technology
Marketwired - Mon Dec 01, 8:03AM CST
Plandaà Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ" or "the Company"
, a developer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that the Company has been highlighted in an article titled "'Secret' Technology Turns Local Farm into Green Tea Extract Factory" in the December edition of the Republic of South Africa's Department of Science & Technology: Public Understanding of Biotechnology Newsletter. The article, which was reviewed by independent experts through the South African Agency for Science and Technology Advancement (SAASTA) Scientific Editorial Process, can be found at: http://www.pub.ac.za/newsletter/02-201412/article-1.html. Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
Marketwired - Tue Nov 18, 11:27PM CST
Plandaà Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the Pheroid® technology to further increase bioavailability in its products. This enhanced bioavailability allows Plandaà to offer a potential solution for many possible viral and infectious diseases.
